Spruce Biosciences Inc.

NASDAQ: SPRB · Real-Time Price · USD
8.75
-0.55 (-5.93%)
At close: Jun 09, 2025, 3:57 PM
8.75
0.00%
After-hours: Aug 13, 2025, 08:00 PM EDT

Spruce Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
38.75M 96.34M 24.49M 42.75M
Short-Term Investments
n/a n/a 54.59M 46.22M
Long-Term Investments
n/a n/a -54.54M 32.46M
Other Long-Term Assets
69K 582K 55.18M 653K
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
5.45M 1.97M 1.21M 396K
Total Current Assets
44.21M 102.18M 83.61M 91.89M
Property-Plant & Equipment
934K 1.18M 1.4M 1.48M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
1M 1.76M 2.04M 34.59M
Total Assets
45.21M 103.95M 85.65M 126.49M
Account Payables
1.29M 3.33M 1.43M 2.82M
Deferred Revenue
n/a 4.91M n/a n/a
Short-Term Debt
1.62M 1.62M 1.62M n/a
Other Current Liabilities
12.33M 11.25M n/a n/a
Total Current Liabilities
15.25M 24.46M 12.45M 8.87M
Long-Term Debt
124K 1.72M 3.29M 4.88M
Other Long-Term Liabilities
1.02M 236K 161K 73K
Total Long-Term Liabilities
1.14M 2.97M 4.71M 6.24M
Total Liabilities
16.39M 27.44M 17.16M 15.12M
Total Debt
2.77M 4.61M 6.18M 6.17M
Common Stock
4K 4K 3K 3K
Retained Earnings
-250.27M -197.23M -149.31M -103.13M
Comprehensive Income
n/a n/a -558K -184K
Shareholders Equity
28.82M 76.51M 68.49M 111.37M
Total Investments
n/a 35K 54.59K 78.68M